Article
The DMT and Psilocin Treatment Changes CD11b+ Activated Microglia Immunological Phenotype
2021-03-08
Abstract excerpt
Psychedelics are new, promising candidate molecules for clinical use in psychiatric disorders such as Treatment-Resistant Depression (TRD) and Post Traumatic Stress Disorder (PTSD). They were recently also proposed as molecules supporting neural tissue repair by anti-inflammatory properties. Here we reported that two classic psychedelics, DMT and psilocin, can influence microglial functions by reducing the level o...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 00fd2c0d-5cd4-562c-bcfd-2cb7d03a3454
- DOI
- 10.1101/2021.03.07.434103
